Actively Recruiting

FEMALE
NCT05579548

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

Led by BioMarin Pharmaceutical · Updated on 2026-03-24

50

Participants Needed

4

Research Sites

514 weeks

Total Duration

On this page

Sponsors

B

BioMarin Pharmaceutical

Lead Sponsor

S

Syneos Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who were exposed to pegvaliase at any time during pregnancy and breastfeeding.

CONDITIONS

Official Title

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

Who Can Participate

FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject or legally authorized representative consent obtained before enrollment
  • Confirmed ongoing pregnancy, including prospective or retrospective based on prenatal testing
  • Diagnosed with phenylketonuria (PKU) according to local care standards
  • Treated with pegvaliase starting from 2 weeks before the last menstrual period
  • Agrees to let study staff contact healthcare providers for medical information
Not Eligible

You will not qualify if you...

  • Currently participating in a BioMarin sponsored interventional study involving investigational products, devices, or procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Syneos Health

Wilmington, North Carolina, United States, 28403

Actively Recruiting

2

Metabolics and Genetics in Calgary (MAGIC)

Calgary, Canada, T2E 7Z4

Actively Recruiting

3

Universitaetsklinikum Hamburg Eppendorf

Hamburg, Germany, 20246

Actively Recruiting

4

Ospedale San Paolo

Milan, Italy, 20142

Actively Recruiting

Loading map...

Research Team

1

165-504 Program Director

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here